1. Home
  2. LICN vs ITRM Comparison

LICN vs ITRM Comparison

Compare LICN & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

N/A

Current Price

$3.29

Market Cap

53.1M

Sector

N/A

ML Signal

N/A

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

N/A

Current Price

$0.38

Market Cap

24.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LICN
ITRM
Founded
2004
2015
Country
China
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
24.3M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
LICN
ITRM
Price
$3.29
$0.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
62.9K
1.0M
Earning Date
01-01-0001
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,641,000.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$0.36
52 Week High
$56.42
$2.10

Technical Indicators

Market Signals
Indicator
LICN
ITRM
Relative Strength Index (RSI) 44.53 34.97
Support Level $3.01 $0.44
Resistance Level $3.74 $0.49
Average True Range (ATR) 0.48 0.04
MACD 0.03 0.00
Stochastic Oscillator 9.38 4.96

Price Performance

Historical Comparison
LICN
ITRM

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: